07:22 AM EDT, 05/01/2024 (MT Newswires) -- Cencora ( COR ) reported fiscal Q2 adjusted earnings Wednesday of $3.80 per diluted share, up from $3.50 a year earlier.

Analysts polled by Capital IQ expected $3.69.

Revenue for the quarter ended March 31 was $68.41 billion, up from $63.46 billion a year earlier.

Analysts surveyed by Capital IQ expected $70.76 billion.

The drug wholesale company said it now expects fiscal 2024 adjusted earnings of $13.30 to $13.50 per diluted share, compared with its prior guidance of $13.25 to $13.50. Analysts polled by Capital IQ expect $13.45.

Cencora ( COR ) maintained its quarterly dividend at $0.51 per share, payable May 24 to shareholders of record on May 10.

Additionally, Cencora ( COR ) said its board approved an up to $2 billion share buyback plan in March.

Shares of the company were down nearly 1% in recent premarket activity.

Price: 238.00, Change: -1.05, Percent Change: -0.44